16:59 , Jul 12, 2017 |  BC Innovations  |  Emerging Company Profile

Epigenetics: It’s personal

Stelvio Oncology is using the wide inter- and intra-tumoral diversity of glioblastoma multiforme (GBM) tumors to create a personalized medicine platform that drives GBM stem cells to adopt benign cell fates based on patient-specific epigenetic...
22:06 , May 11, 2017 |  BC Innovations  |  Tools & Techniques

Stemming the tide

OncoMed’s bad April has all the hallmarks of a death knell for the once-promising technology of cancer stem cells, adding to the pile of preclinical breakthroughs that didn’t translate to the clinic. But many insiders...